Tackle Cancer Challenge, A Huge Thank You!
In this first edition of the Tackle Cancer Challenge, we [...]
Cu-64-SAR-Bombesin PET-CT imaging for metastatic breast cancer
Keith Wong - 2022 ASCO Meeting - Poster Session - [...]
Tackle Cancer Challenge: It’s a wrap!
With more than 300 participants and 15000 kilometers reached in [...]
May 30 – Webinar – PSMA PET/CT Beyond the Images
Event: Canadian Urological Association (CUA) Webinar - PSMA PET/CT Beyond [...]
ANZSNM 2022 – Brisbane, Australia
Event: 52nd Annual Scientific Meeting of the Australian and New [...]
8th International Symposium on Medical Radioisotopes
Event: 8th International Symposium on Medical Radioisotopes | Challenging Initiatives [...]
March 2022 – The Second Edition of Radiotheranostics Today is out!
Today we celebrate the 81st anniversary of the first radioiodine [...]
Lu-177-PSMA-617 approved by FDA for prostate cancer patients
Novartis has obtained US Food and Drug Administration (FDA) marketing [...]
Novel Radioligand Proven Superior for Metastatic Prostate Cancer
Novel Radioligand Therapy Proven Superior for Metastatic Prostate Cancer Patients [...]
Rare is Many
Do you know that there are 300 million people worldwide [...]